The quantity of bcr-abl fusion gene, as the initiation and core factor of CML pathogenesis, is positively correlated with the PD-1 expression level on CD8+ T cells. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.